Questcor Pharmaceuticals, a biopharmaceutical company, with headquarters in California, USA has announced about 6 deals since 2009. Analysis of the partnering deals shows a strong emphasis on deals announced in neurology, nephrology and rheumatology therapeutics areas. Questcor Pharmaceuticals is a small company with a very promising product pipeline. It is listed as a big biotech company by Current Partnering based on global biotech sales.
Questcor Pharmaceuticals encourages professional growth without boundaries. It is keen to partner with companies who share their vision in improving the lives of patients with difficult to treat autoimmune and inflammatory disorders.
The following figure shows the level of Questcor Pharmaceuticals partnering deal announcements since 2005.
Figure 1: Questcor Pharmaceuticals partnering deals 2009-2014
Figure 1: Questcor Pharmaceuticals partnering deals 2009-2014
Source: Current Agreements, 2014
The following table provides an overview of the partnering deals announced by Questcor Pharmaceuticals based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Deals and Alliances with Questcor Pharmaceuticals
Figure 2: Questcor Pharmaceuticals partnering deals by therapy area 2009-2014
Figure 2: Questcor Pharmaceuticals partnering deals by therapy area 2009-2014
Source: Current Agreements, 2014
Further analysis of these deals shows that Questcor Pharmaceuticals has a preference for asset purchase, R&D, licensing and technology transfer deals similar to many other top pharmaceutical or big biotech companies. Such partnering deals provide the right for Questcor Pharmaceuticals to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.
The following table provides an overview of the partnering deals announced by Questcor Pharmaceuticals based on deal type disclosed.
Figure 3: Questcor Pharmaceuticals partnering deals by deal type 2009-2014
Source: Current Agreements, 2014
The following table provides an overview of the partnering deals announced by Questcor Pharmaceuticals based on stage of development at signature.
Figure 4: Questcor Pharmaceuticals partnering by stage of development 2009-2014
Figure 4: Questcor Pharmaceuticals partnering by stage of development 2009-2014
Source: Current Agreements, 2014
The majority of deals are discovery and marketed stage deals whereby the licensee obtains a marketing right or an option to co market or market the licensors product candidates.
Questcor Pharmaceuticals has not signed very high value deals being a small company. They have strategically partnered to enhance their product pipeline and to grow as a strong industry.
Figure 5: Top Questcor Pharmaceuticals partnering deals by headline value 2009-2014
Figure 5: Top Questcor Pharmaceuticals partnering deals by headline value 2009-2014
Source: Current Agreements, 2014
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Questcor Pharmaceuticals
Questcor Pharmaceuticals partnering at Current Agreements
View all partnering deals for Questcor Pharmaceuticals: 2014 | 2013 | 2012 | 2011 | 2010 | 2009
Full details on each deal can be found at CurrentAgreements (subscription required)
Or purchase report: Partnering Deals and Alliances with Questcor Pharmaceuticals
More
Summary profile data for Questcor Pharmaceuticals
Partnering interests for Questcor Pharmaceuticals
M&A activity for Questcor Pharmaceuticals
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Questcor Pharmaceuticals
Available resources for deal coverage for Questcor Pharmaceuticals
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on Questcor Pharmaceuticals company profile, recent partnering, M&A and financing news and articles
Related
Report: View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk
Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter
